Date/Time
20:00 UTC on Tuesday 26 May 2020 - 90 minutes.
Objectives
- Bindings to FHIR Clinical Resources (e.g. value set bindings)
Meeting Details
Online: https://snomed.zoom.us/my/snomedhl7
Phone: See https://zoom.us/zoomconference for available phone numbers (meeting id 242-348-6949)
Chat: snomedIntl.slack.com #snomed-hl7-fhir
Discussion items
Item | Description | Mins | Owner | Notes & Actions | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Welcome and introductions | 5 | Recording + Notes. | |||||||||||||
2 | Summary of previous week (TS) and previous TB | 5 | ||||||||||||||
3 | Future meetings | 5 | FHIR DevDays - June 16-18, 2020 Cleveland, OH. Virtual Event HL7 Baltimore September 18 - 25 SI Business + Expo October. 5 May 2020 Discuss SNOMED on FHIR Presentation. Suggestion that the Sunday event could go ahead if we're there anyway, but a fully online call would not provide sufficient benefit over and above a Tuesday call.
| |||||||||||||
4 | COVID-19 known exposure | Topic requires a sponsor for group discussion | ||||||||||||||
5 | cocos.team (German) | Daniel Karlsson | https://translate.google.co.uk/translate?sl=auto&tl=en&u=cocos.team%2Fterminologie.html Update 26 May: Ian Green has been working with this Group and has brought requirements for SI COVID-19 back. Valueset example: https://art-decor.org/art-decor/decor-valuesets--covid19f-?language=de-DE&id=1.2.276.0.76.11.466 | |||||||||||||
6 | Immune Status | Rob Hausam | IPS received request on how to manage a statement of immunity to a disease (eg COVID-19) See group chat discussion. In general, declaring Immunity is problematic. From a legal perspective as well as clinical ie you can say antibodies are present but whether or not that guarantees immunity is not obvious. | |||||||||||||
7 | COVID-19 | 35 | A COVID-19 Guide is in development.
Use of Observation et al. resources for identifying laboratory, PoC and/or home tests plus combinations like patient specimen collection for lab test. A combination of Observation, Specimen, Device, and DeviceDefinition resources could meet such needs. Also, new Observation.code values will likely be created to allow this differentiation as well. See cv19 , HL7 IG http://covid-19-ig.logicahealth.org , http://build.fhir.org/ig/HL7/fhir-saner/ , https://covid-19-ig.logicahealth.org/SignsSymptoms.html Linda has done a comparison of SI vs HL7 ValueSets see https://docs.google.com/spreadsheets/d/1P3DgnLOvr31H4cIfRa_cTfkdhBCC8acTzPCbHmjakrI/edit?usp=sharing Snomed on FHIR Analysis: COVID-19 Symptoms Present WHO Case Report form discussed with LogicaHealth. WHO Case Reporting form form contains finding context values (known present, known absence, unknown)
2020-04-28: German FHIR profiles here: http://cocos.team/profile.html 2020-05-12: Linda suggested discussing the Interoperability Alliance work next time. See http://www.snomed.org/news-and-events/articles/snomed-joins-covid19-interoperability-alliance | |||||||||||||
8 | ||||||||||||||||
9 | Revisit Immunization | 5 | April 14: A generic SNOMED CT concept for "key worker" (or just "target population") is needed to state an immunization reason, or a reason for an immunization recommendation. | |||||||||||||
10 | Follow up on Blood Pressure. | 10 | Is the "vital signs" scope too limited? Distinction being made between "Vital Signs" blood pressure and general blood pressures. No conclusion reached on "panel codes". Compromise to use whatever is recorded on the system and where none available use a high level concept. Update 17 March: DK - NHS Limiting Scope, any update? Answer: No. Decided to transmit all blood pressures and other < 248326004 |Body measure (observable entity)| (blood pressure is not a body measure!), but only those that met the FHIR binding would have the LOINC code and relevant category. | |||||||||||||
11 | Specimen | 30 | Ulrike Merrick | Specimen binding. Update from HL7 Specimen Project Group by Ulrike Merrick (and offer to review this group's work!) DK Both FHIR and SNOMED have reasonably elaborate models for dealing with these which creates "interesting" opportunities for binding discussions. Discussion on why Specimen (which - as an industry - has been around forever) is only at maturity level 2. Perhaps there's a lack of production implementations. DK: Specimen is a potential candidate for a SOF Published Profile. | ||||||||||||
12 | Implementation Guide | 31 | The Implementation Guide is now building fine. Please everyone have a look and share comments. http://build.fhir.org/ig/IHTSDO/snomed-ig/index.html | |||||||||||||
13 | Cancer Disease Status | Carmela Couderc | http://hl7.org/fhir/us/mcode/2019Sep/StructureDefinition-onco-core-CancerDiseaseStatus.html http://hl7.org/fhir/us/mcode/2019Sep/ValueSet-obf-datatype-ConditionStatusTrendVS.html
Query about qualifier values used. Would it be better to use < 418138009 |Patient condition finding (finding)| ? (JR suggested immediate children ie "<!" rather than descendants) See also 373117000 |Pathology examination findings indeterminate (finding)| (child of 250537006 |Histopathology finding (finding)|) Update 31 March 2020 - PWI: links above no longer work. I was unable to find obvious alternative via http://hl7.org/fhir/us/mcode/ | |||||||||||||
14 | Exemplar Profile | Publishing Profiles
Options for Profile discussion:
Notes 26 Feb: UK working on pathology reporting - diagnostic / observation. Suggestion that we try out two types of profile, both of which avoid issues of conflict between fields within the information model:
28 May: Plan to publish profile for the October conference (8 sessions + working between meetings. Completion for review Tues 14 October (or earlier since we'll need time to complete the IG?)
Tooling for profiles: Forge (.NET) is now R4 14 Jan 2020: Update from Rob on his progress with a new FHIR Template infrastructure. Required migrating/juggling what we had already built on older infrastructure. Sits under our implementation guide materials at build.fhir.org/ig/IHTSDO/snomed-ig/branches/new-template/ as Option 6: SNOMED Specific Profiles Differential Table view shows the difference between the parent resource and our SNOMED-specific further profiling of it. Discussion around practicalities of handling bindings where the ECL isn't very pretty, but the enumerated membership list could change very frequently e.g. a list of codes for vaccine preparations (or procedures) that are specifically relevant to some national childhood immunisation programme, and which can therefore change monthly as new vaccine preparations become available. Preferred implementation solution would be for suppliers to be able to consume ECL, however complex. Discussion about what kind of separation should exist between the Implementation Guide (which should list things we think everybody should be doing in some certain way) and any more discursive musings that have have not reached that level of consensus or experience. Thoughts on whether the IG should be balloted, and how to assess the maturity of any of it? Should each SNOMEDonFHIR published profile have its own (1-5) maturity metric stated?
RH: Suggestion that "published" valuesets would be read-only.
| ||||||||||||||
15 | Next meeting | 5 | 9 June 2020 |
Meeting Files